Effect of recombinant human erythropoietin in preterm infants

European Journal of Haematology

Volumn 63, Issue 2, 1999, Pages 71-76

  Krallis, Nikolaos ^a   Cholevas, Vasilis ^a   Mavridis, Anestis ^b   Georgiou, Ioannis ^c   Bourantas, Konstantinos ^c   Andronikou, Styliani ^a,c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Red blood cell organic Pi compounds; rHuEpo; sTfR

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; FERRITIN; HEMOGLOBIN; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; GESTATIONAL AGE; HUMAN; INFANT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032773334     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01119.x     Document Type: Article

References (21)

1. 1. BROWN MS, GARCIA JF, PHIBBS RH, DACLMAN PR. Decreased response of plasma immunoreactive erythropoietin to available oxygen in anemia of prematurity. J Pediatr 1984;105:793-798.
2. 2. STOCKMAN JA III, GARCIA JF, OSKI FA. The anemia of prematurity. Factors governing the erythropoietin response. N Engl J Med 1977;296:647-650.
3. 3. SOUBASI V, KREMENOPOULOS G, DIAMANTI E, SARAFIDIS K, TSAKIRIS D. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995;127:291-297.
4. 4. HALPERIN DS, FELIX M, WALKER P, LACOURT G, BABEL J-F, WEISS M. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr 1992;151:661-662.
5. 5. PUNNONEN K, IRSALA K, RAJAMAKI A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-1057.
6. 6. KHONGO Y, NIITSU Y, KONDO H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70:1955-1958.
7. 7. OSKI FA, DELIVORIA-PAPADOPOULOS M. The red-cell 2,3-diphosphoglycerate and tissue oxygen release. J Pediatr 1970;77:941-956.
8. 8. CHOLEVAS V, CHALLA A, LAPATSANIS D, ANDRONIKOU S. Phosphate metabolism in the red cell of sick prematures. Bone Mineral 1993;22:177-185.
9. 9. OBLADEN M, MAIER RF. Erythropoietin therapy in preterm infants. In HANSEN TN, MCINTOSH N, eds. Current Topics in Neonatology. London: Saunders, 1997;108.
10. 10. CHALLA A, BEVINGTON A, ANGER CM, ASBURY AJ, PRESTON CJ, RUSSELL RGG. A technique for the measurement of orthophosphate in human erythrocytes and some studies of its determinants. Clin Sci 1985;629:429-434.
11. 11. BOURANTAS K, ECONOMOU G, GEORGIOU G. Administration of high doses of recombinant human erythropoietin to patients with β-thalassemia intermedia: a preliminary trial. Eur J Haematol 1997;58:22-25.
12. 12. SHANNON KM, KEITH JM, MENTZER WC, et al. Recombinant erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants, Pediatr 1995;95;1-8.
13. 13. BROWN MS, PHIBBS RH, GARCIA JF, DALLMANN PR. Postnatal changes in erythropoietin levels in untransfused premature infants. J Pediatr 1983;103:612-617.
14. 14. BROWN MS, GARCIA JF, PHIBBS RH, DALLMANN PR. Decreased response of plasma immunoreactive erythropoietin to «available oxygen» in anemia of prematurity. J Pediatr 1984;105:793-798.
15. 15. MIZUNO S, SASAKI J, SUZZUKI C, KONO H, KOSMA S. Effect of recombinant human erythropoietin administration in peripheral blood neutrophil counts of premature infants. J Pediatr 1994;124:467-470.
16. 16. SHANNON KM, MENTZER WC, ABELS RI, et al. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991; 118:949-955.
17. 17. BECHENSTEEN AG, REFSUM HE, HALVORSEN S, HAGA P, LIESTOL K. Effects of recombinant human erythropoietin on fetal and adult hemoglobin in preterm infants. Pediatr Res 1995;38:729-732.
18. 18. SOUBASI V, KREMENOPOULOS G, DIAMANTI E, TSANTALI C, TSAKIRIS D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study. Pediatr Res 1993;34:675-679.
19. 19. LUNDSTROM U, SIIMES MA, DALLMANN PR. What age does iron supplementation become necessary in low birth weight infants. J Pediatr 1977;81:878-883.
20. 20. KIVTVUORI SM, HEIKINGHEIMO M, TEPPO AM, SIIMES MA. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very low birth weight infants. Pediatr Res 1994;36:85-89.
21. 21. ALLEN J, BACKSTROM KR, COOPER JA, et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem 1998;44:35-39.